Draft:Psychedelic Medicine

  • Comment: As a matter of fact, this article is probably showing symptoms of WP:NOTEBOMB. Some poorer quality sources may need removal. Pygos (talk) 03:01, 12 November 2024 (UTC)
  • Comment: As far as I can see, there are no independent sources discussing the journal. I have no access to the Davies article, but from the first paragraph it seems to be an interview with the two co-editors, so this isn't a source as required for WP:GNG either. As for the references to articles published in the journal, yes, a section "notable articles" is allowed and even desired, provided that those articles have been selected according to an objective criterion. A selection made following the opinion of a WP editor is not acceptable. At this point, I'm not going to look at other Liebert journal articles, because that is irrelevant (see WP:OTHERSTUFFEXISTS). Randykitty (talk) 09:22, 11 November 2024 (UTC)
  • Comment: Have added more information to the page/further expanded. Re: sourcing, per WP:NEWSORG, less-established news outlets are less-preferred as sources but seem to be acceptable for "statements of fact" and don't appear to be explicitly barred. There is also the more formal journal article Davies (2022). Will resubmit for consideration one last time. Thank you. – 76.174.0.57 (talk) 01:10, 11 November 2024 (UTC)
  • Comment: Hi Randykitty. Thanks for reviewing the submission. There is an independent journal source that's not from the journal (i.e., Davies, 2022). The refs from the journal itself weren't intended to support the notability of the page, they were just to expand/flesh out the content a little more, as requested by the previous reviewer. I hope that you can take another look. I'll see what else I can further add to the page as well. – 76.174.0.57 (talk) 23:37, 10 November 2024 (UTC)
  • Comment: We need sources about the journal, not from the journal. Randykitty (talk) 23:01, 10 November 2024 (UTC)
  • Comment: I have added further sources, including independent sources published not just in the news but in formal journals. As far as I can tell, the sources fulfill notability and reliability criteria. Note also other similar Mary Ann Liebert journal pages here on Wiki which often have much less sourcing than this page. Requesting reconsideration. Thank you. – 76.174.0.57 (talk) 22:19, 10 November 2024 (UTC)

Psychedelic Medicine
DisciplinePsychedelic drugs; Medicine
LanguageEnglish
Edited byPeter Hendricks; Charles Nichols
Publication details
History2023–present
Publisher
Mary Ann Liebert (United States)
FrequencyQuarterly
Hybrid
Standard abbreviations
ISO 4Psychedelic Med (New Rochelle)
Indexing
ISSN2831-4425 (print)
2831-4433 (web)
LCCN2022200469
OCLC no.1304260166
Links

Psychedelic Medicine is a peer-reviewed quarterly academic journal on the use of serotonergic psychedelics as therapeutic agents in medicine.[1][2][3][4] Its co-editors-in-chief are Peter Hendricks and Charles Nichols.[1][3][4] Nichols is the son of psychedelic researcher David E. Nichols.[5][6] The journal launched in 2023.[1][4][7] It is published by Mary Ann Liebert.[1][4][7]

Some notable topics that have been reviewed in Psychedelic Medicine include consensus definition of psychedelics,[8] psychedelic commercialization,[9] psychedelic-assisted therapy,[10] whether psychedelic therapists should have personal experience with psychedelics,[11][12] entactogens like MDMA for treatment of autistic spectrum disorders,[13] psychedelic clinical trial design,[14] and psychedelics for reduction of chronic shame in sexual and gender minorities,[15] among others.[1]

Psychedelic Medicine is the first medical journal to be exclusively focused on psychedelics.[1] It is included in the National Library of Medicine (NLM)'s publication catalog, and select publications of the journal are indexed in PubMed.[16] It is also included in the Library of Congress's catalog.[17]

References

edit
  1. ^ a b c d e f Davies, Kevin (1 January 2022). "No Hallucination: The Launch of Psychedelic Medicine". GEN Edge. 4 (1): 892–895. doi:10.1089/genedge.4.1.150. ISSN 2768-1580.
  2. ^ Price, Stephanie (5 May 2022). "New peer-reviewed psychedelics journal to launch in 2023". Psychedelic Health. Retrieved 10 November 2024.
  3. ^ a b "Psychedelic Medicine Is Focus of New Journal". Mirage News. 31 October 2022. Retrieved 10 November 2024.
  4. ^ a b c d "Peter Hendricks named co-editor-in-chief of new journal, Psychedelic Medicine". Home - The University of Alabama at Birmingham. 3 April 2023. Retrieved 10 November 2024.
  5. ^ Vargas, Ramon Antonio (27 July 2009). "LSU researcher and his father strive to aid mental health by studying rats, flies drugged with LSD". NOLA.com. Retrieved 11 November 2024.
  6. ^ Mind & Matter (6 February 2024). "DMT, Serotonin, Inflammation, Psychedelics, and Past, Present & Future of Psychedelic Medicine". Apple Podcasts. Retrieved 11 November 2024.
  7. ^ a b "New peer-reviewed journal Psychedelic Medicine launching in 2023". EurekAlert!. Retrieved 10 November 2024.
  8. ^ Nichols, David E.; Nichols, Charles D.; Hendricks, Peter S. (1 March 2023). "Proposed Consensus Statement on Defining Psychedelic Drugs". Psychedelic Medicine. 1 (1): 12–13. doi:10.1089/psymed.2022.0008. ISSN 2831-4425.
  9. ^ Aday, Jacob S.; Barnett, Brian S.; Grossman, Dan; Murnane, Kevin S.; Nichols, Charles D.; Hendricks, Peter S. (1 September 2023). "Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry". Psychedelic Medicine. 1 (3): 150–165. doi:10.1089/psymed.2023.0013. ISSN 2831-4425.
  10. ^ Turner, Thivya; Glue, Paul (15 October 2024). "Systematic Review of the Effect of Psychedelic-Assisted Therapy on Attitudes Toward Death, Life, and Spirituality on Symptoms of Distress, Depression, and/or Anxiety in Patients with Life-Threatening Illness". Psychedelic Medicine. doi:10.1089/psymed.2024.0008. ISSN 2831-4425.
  11. ^ Earleywine, Mitch; Gomez, Samantha G. (1 September 2024). "Is Personal Experience Essential for Effective Psychedelic Therapists?: The Challenges of Small, Accumulating Therapist Effects". Psychedelic Medicine. 2 (3): 138–145. doi:10.1089/psymed.2023.0054. ISSN 2831-4425.
  12. ^ Dames, Shannon; Watler, Crosbie; Kryskow, Pamela; Allard, Pearl; Gagnon, Michelle; Taylor, Wes; Tsang, Vivian W.L. (1 September 2024). "Psychedelic-Assisted Therapy Training: An Argument in Support of Firsthand Experience of Nonordinary States of Consciousness in the Development of Competence". Psychedelic Medicine. 2 (3): 130–137. doi:10.1089/psymed.2023.0004. ISSN 2831-4425.
  13. ^ Kaur, Harpreet; Karabulut, Sedat; Gauld, James W.; Fagot, Stephen A.; Holloway, Kalee N.; Shaw, Hannah E.; Fantegrossi, William E. (1 September 2023). "Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder". Psychedelic Medicine. 1 (3): 166–185. doi:10.1089/psymed.2023.0023. ISSN 2831-4425.
  14. ^ Wen, Alexander; Singhal, Nikhita; Jones, Brett D.M.; Zeifman, Richard J.; Mehta, Shobha; Shenasa, Mohammad A.; Blumberger, Daniel M.; Daskalakis, Zafiris J.; Weissman, Cory R. (1 March 2024). "A Systematic Review of Study Design and Placebo Controls in Psychedelic Research". Psychedelic Medicine. 2 (1): 15–24. doi:10.1089/psymed.2023.0028. ISSN 2831-4425.
  15. ^ Carlisle, Nicholas A.; Dourron, Haley Maria; MacCarthy, Sarah; Zarrabi, Ali John; Hendricks, Peter S. (1 December 2023). "Exploring the Unique Therapeutic Potential of Psychedelics to Reduce Chronic Shame Among Sexual and Gender Minority Adults". Psychedelic Medicine. 1 (4): 210–217. doi:10.1089/psymed.2022.0018. ISSN 2831-4425.
  16. ^ "Psychedelic Medicine". NCBI. 22 October 2024. Retrieved 10 November 2024.
  17. ^ "Item Information (Full Record)". LC Catalog. Retrieved 11 November 2024.
edit